IS THERE A COMMON, HIGH-AFFINITY OPIOID BINDING-SITE IN RAT-BRAIN

At low concentrations, 3H-naloxone apparently bound to two sites, of high (KD 0.50 nM) and low (KD 2.0nM) affinity. Binding to the high affinity site was preferentially blocked by naloxonazine. This is consistent with the high and low affinity sites representing the .mu.1 and .mu.2 sites respectively. Binding of 3H-naloxnone to the .mu.1 and .mu.2 sites was differentially inhibited by opioids. Compared to .mu.2 binding, DADLE and DAGO preferentially inhibited .mu.1 binding. DADLE inhibited the binding of 3H-DAGO potently and in a competitive manner. DAGO inhibited the binding of 3H-DADLE from two sites for which DAGO had high and low affinities. Scatchard analysis indicated that both 3H-DAGO and 3H-DADLE bound to one class of sites, with 3H-DADLE having a 2-3 fold greater Bmax. It is concluded that 3H-opioids bind to at least three sites -.mu.1, .mu.2 and .delta.. The .mu.1 site represents a high affinity binding site for both opioid peptides and opioid alkaloids. DAGO is a selective ligand for the .mu.1 site, whilst DADLE interacts with .mu.1 and .delta. sites with similar affinities.